This book aims to provide a synthesis of current information on the mechanisms and treatment of two of the most common side effects of anti-cancer therapy - nausea and vomiting. In the past three years, considerable progress has been made towards understanding the neuropharmacology of emesis induced by anti-cancer therapy. The novel class of 5HT3-receptor antagonist anti-emetics are therefore considered in a physiological and clinical context. Also covered are the practical means of measuring nausea and vomiting, the psychological impact of cancer treatment, and the care of cancer patients from the oncology nurse's point of view.
